Gliknik invests a significant percentage of its expenses into development of its intellectual property portfolio. For about a decade, Gliknik has been represented by Cooley LLP on intellectual property matters.
In our latest complete year Gliknik had 36 patents issued in 32 countries across 3 patent families.
Gliknik patent filings are worldwide. These are issued US patents that are either owned by or licensed by Gliknik:
- U.S. Patent No. 8,680,237 “Immunoglobulin Constant Region FC Receptor Binding Agents”
- U.S. Patent No. 9,512,208 “Immunoglobulin Constant Region FC Receptor Binding Agents”
- U.S. Patent No. 9,512,210 “Immunoglobulin Constant Region FC Receptor Binding Agents”
- U.S. Patent No. 9,683,044 “Molecules with Antigen Binding and Polyvalent FC Gamma Receptor Binding Activity“
- U.S. Patent No. 9,926,362 “Immunoglobulin Constant Region FC Receptor Binding Agents”
- U.S. Patent No. 10,208,105 “Immunoglobulin Constant Region FC Receptor Binding Agents”
- U.S. Patent No. 10,851,154 “Immunoglobulin constant region FC receptor binding agents”
- U.S. Patent No. 10,941,191 “Immunoglobulin constant region FC receptor binding agents”
- U.S. Patent No. 11,034,775 “Cysteine-optimized stradomers”